Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
Pharmacol Res
; 123: 40-50, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-28648738
Key words
Angiotensin II type 1 receptor; Azilsartan (PubChem CID: 9825285); Biased agonism; Candesartan (PubChem CID: 2541); Conformational change; EXP3174 (PubChem CID: 108185); Eprosartan (PubChem CID: 5281037); G-protein coupled receptor; Inverse agonism; Irbesartan (PubChem CID: 3749); Losartan (PubChem CID: 3961); Olmesartan (PubChem CID: 158781); Receptor dimerization; Telmisartan (PubChem CID: 65999); Valsartan (PubChem CID: 60846)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptor, Angiotensin, Type 1
Limits:
Animals
/
Humans
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2017
Document type:
Article
Country of publication:
Países Bajos